Yuval Cohen
Directeur Général chez CORBUS PHARMACEUTICALS HOLDINGS, INC.
Fortune : 3 M $ au 31/05/2024
Postes actifs de Yuval Cohen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 11/04/2014 | - |
| Directeur Général | 11/04/2014 | - | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Directeur/Membre du Conseil | 01/07/2013 | - |
| Directeur Général | 01/07/2013 | - |
Historique de carrière de Yuval Cohen
Anciens postes connus de Yuval Cohen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2005 | 01/02/2013 |
| Fondateur | 01/01/2005 | 01/12/2013 | |
| Corporate Officer/Principal | 01/02/2013 | 01/12/2013 | |
| President | 01/01/2005 | 01/02/2013 |
Formation de Yuval Cohen
| University of Cape Town | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Royaume-Uni | 2 |
| Afrique du Sud | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
- Bourse
- Insiders
- Yuval Cohen
- Expérience
